August 4, 2021 by Jason Wertheimer Endpoints News Jeff Bluestone just raised $265M to develop curative cell therapies. We asked him how Learn More
July 14, 2021 by Jason Wertheimer Nature Creating T cells to guard against autoimmune disease Learn More
October 1, 2020 by Jason Wertheimer LinkedIn The time is now: Autoimmune and inflammatory diseases, meet regulatory T-cell therapy Learn More
September 30, 2020 by Jason Wertheimer Endpoints News Sonoma Bio named as one of most promising startups in biotech by Endpoints News Learn More
September 30, 2020 by Jason Wertheimer Endpoints News Jeffrey Bluestone recruits a trio of biopharma vets to the startup team at Sonoma — while adding $30M to the launch round Learn More